These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7049057)

  • 1. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition.
    Slonim AE; Weisberg C; Benke P; Evans OB; Burr IM
    Ann Neurol; 1982 Apr; 11(4):420-2. PubMed ID: 7049057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet therapy in severe clinical expression of debrancher deficiency.
    Azael Meza A; Ayub M; Cantú JM; Flores J
    Arch Invest Med (Mex); 1991; 22(3-4):285-8. PubMed ID: 1844114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrition therapy for hepatic glycogen storage diseases.
    Goldberg T; Slonim AE
    J Am Diet Assoc; 1993 Dec; 93(12):1423-30. PubMed ID: 8245377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous nocturnal intragastric feeding in glycogenosis type I and III].
    de Parscau L; Guibaud P; Hermier M; François R
    Pediatrie; 1986; 41(3):197-203. PubMed ID: 3095784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cornstarch therapy in a patient with type III glycogen storage disease.
    Borowitz SM; Greene HL
    J Pediatr Gastroenterol Nutr; 1987; 6(4):631-4. PubMed ID: 3480949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional therapy for glycogen storage diseases.
    Heller S; Worona L; Consuelo A
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47 Suppl 1():S15-21. PubMed ID: 18667910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Debrancher deficiency: neuromuscular disorder in 5 adults.
    DiMauro S; Hartwig GB; Hays A; Eastwood AB; Franco R; Olarte M; Chang M; Roses AD; Fetell M; Schoenfeldt RS; Stern LZ
    Ann Neurol; 1979 May; 5(5):422-36. PubMed ID: 288318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy.
    Slonim AE; Coleman RA; Moses WS
    J Pediatr; 1984 Dec; 105(6):906-11. PubMed ID: 6438290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid disturbances in type III glycogenosis: differences from type I glycogenosis.
    Slonim AE; Coleman RA; Moses S; Bashan N; Shipp E; Mushlin P
    Metabolism; 1983 Jan; 32(1):70-4. PubMed ID: 6336817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and growth of children with glycogen storage disease Types I and III.
    Daeschel IE; Janick LS; Kramish MJ; Coleman RA
    J Am Diet Assoc; 1983 Aug; 83(2):135-41. PubMed ID: 6409953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal intragastric therapy in type I glycogen storage disease: effect on hormonal and amino acid metabolism.
    Slonim AE; Lacy WW; Terry A; Greene HL; Burr IM
    Metabolism; 1979 Jul; 28(7):707-15. PubMed ID: 286865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low level of fasting plasma mannose in a child with glycogen storage disease type 0 (liver glycogen synthase deficiency).
    Miwa I; Taguchi T; Asano H; Murata T; Yorifuji T; Nagasaka H; Takatani T
    Clin Chim Acta; 2010 Jul; 411(13-14):998-9. PubMed ID: 20331987
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of glycogenosis type III with total parenteral nutrition, continuous intragastric infusion and D-thyroxine].
    Böhles H; Dick W; Scharf J
    Infusionsther Klin Ernahr; 1982 Aug; 9(4):160-1. PubMed ID: 6813261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic adaptation in the fasting test in children with glycogenoses types III and IV].
    Bührdel P; Böhme HJ; Hubald J
    Kinderarztl Prax; 1987 Nov; 55(11):543-8. PubMed ID: 3481641
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet.
    Valayannopoulos V; Bajolle F; Arnoux JB; Dubois S; Sannier N; Baussan C; Petit F; Labrune P; Rabier D; Ottolenghi C; Vassault A; Broissand C; Bonnet D; de Lonlay P
    Pediatr Res; 2011 Dec; 70(6):638-41. PubMed ID: 21857385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glycogen storage disease by amylo 1,6-glucosidase deficiency (author's transl)].
    Méndez Aparicio FM
    An Esp Pediatr; 1980 Oct; 13(10):901-8. PubMed ID: 6937153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose uptake in horses with polysaccharide storage myopathy.
    De La Corte FD; Valberg SJ; MacLeay JM; Williamson SE; Mickelson JR
    Am J Vet Res; 1999 Apr; 60(4):458-62. PubMed ID: 10211689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen storage disease type I and III and pyruvate carboxylase deficiency: results of long-term treatment with uncooked cornstarch.
    Ullrich K; Schmidt H; van Teeffelen-Heithoff A
    Acta Paediatr Scand; 1988 Jul; 77(4):531-6. PubMed ID: 3134793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Forbes-Cori disease: reversible worsening in a case with non-evolutive neuromuscular disorder].
    Martínez Matos JA; Vila Duplá MJ; Montero J; Ferrer I; Baguñá J; Peres Serra J
    Neurologia; 1987; 2(2):75-80. PubMed ID: 3078946
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycogen storage disease: recommendations for treatment.
    Fernandes J; Leonard JV; Moses SW; Odièvre M; di Rocco M; Schaub J; Smit GP; Ullrich K; Durand P
    Eur J Pediatr; 1988 Apr; 147(3):226-8. PubMed ID: 3292244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.